Magalie Wasem Tréguer. Executive Summary. Säntisstrasse 93, 8820 Wädenswil, Switzerland +41 (0) / +41 (0)

Similar documents
Healthcare and Life Sciences

Jean W. Frydman Partner

Kenneth L. Bachman, Jr.

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

- University of St. Gallen (M.A. HSG in Law, 2010) - London School of Economics and Political Science (LL.M., 2016)

Sebastian Burckhardt

MENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS

THE DUTCH LEGAL LANDSCAPE FOR THE HEALTHCARE AND LIFE SCIENCES SECTORS

Life Sciences Regulatory

Dr Rupert Bellinghausen

CPD Bootcamp. Adding value to your role as in-house counsel: Working together to deliver value to our mutual clients.

Cannabis Practice Group

Mara H. Rogers, Partner Norton Rose Fulbright

LISA TILTON-McCARTHY

Membership of the Independent Expert Oversight Advisory Committee

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Karen Cheah Yee Lynn Partner

Monitoring R&D resource flows: Global resources and challenges

WILSON SONSINI GOODRICH & ROSATI

Enhancing Audit Quality and Transparency Supplement Additional information required by Article 13 of EU Regulation 537/2014

experience knowledge innovation

Latin America. Pillsbury Winthrop Shaw Pittman LLP pillsburylaw.com

1004: Corporate Communications and Attorney-Client Privilege: What You Need to Know

WIPO LIST OF NEUTRALS BIOGRAPHICAL DATA. Telephone: Fax:

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.

Enayat Qasimi. Partner. Experience M Street, NW Suite 450N Washington, DC Phone: Fax:

the practice of law the way it should be

P r e s e n t a t i o n. We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China.

arbitration commercial disputes corporate Get The Right Lawyer For The Right Advice From Prominent Indonesian Law Firm

JOB ACCOUNCEMENT: DIRECTOR OF PRO BONO PARTNERSHIPS

Global Leadership in Law and Business for Non-U.S. Lawyers

Teresa V. Pahl Partner

WHO WE SERVE. Regulators Business and Law Schools. Executives and Staff Job Seekers & Students

Be inspired. Your future with Orrick in Asia

A GLOBAL REACH MEDIA KIT

JURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS

CANADIAN CENTRE FOR ETHICS AND CORPORATE POLICY. Annual General Meeting. May 17, :30 7:00 pm

Terri Bradford Eason manages the foundation s Gift Planning Program as a member of the Advancement team. Her primary focus is cultivating

Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada

EVCA Strategic Priorities

JONATHAN GOLDBERG Chief Executive Officer Global Business Solutions

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

PRACTICAL STRATEGIES FOR DOING BUSINESS IN CHINA Thursday, October 25, 2007

Denis Brock Partner. Experience

Building Wealth and Prosperity in the Communities We Call Home

Israeli Desk. Legal and Tax Advice

Ask the Regulator and Industry Experts Thursday, September 14 3:30 p.m. 4:30 p.m.

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

PANEL DISCUSSION & ROUNDTABLES

PETIA DIMITROVA. Country CEO and Chairperson of the Management Board of Eurobank Bulgaria AD (Postbank) Present

LUIS CARLOS RODRIGO PRADO Lima - Perú, Ford Foundation Scholarship Research on International Arbitration at Yale Law School (1993)

CURRICULUM VITAE. Alastair David Maclean. Senior leader with considerable commercial and change management experience

B i o g r a p h y Steven M. Egna Steven M. Egna

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Faculty. Executive LLM Program

Dr.Chandrasekaran is a prolific writer and speaker and his numerous articles have been published in newspapers and law journals.

This brochure contains a profile of four candidates standing for one of Mexico s two seats on the CSA:

Goldberg Jonathan South African Chief Executive Officer - Global Business Solutions

DIRECTORS EDUCATION PROGRAM

As President and CEO Jonathan has spoken on a number of information technology and security topics for the Ohio Society of Certified Public

International Presence, Local Expertise. Introductory Presentation

CANDIDATES FOR ELECTION TO THE 2018 COUNCIL

Robert S. Harrell, Head of Financial Institutions and Insurance,...

Unitary patent & Unified Patent Court

David Jenny. General. Education

Public Private Partnerships & Idea selection

Koen Dejonckheere. Professional experience. Board Memberships. Education

W. Kenneth Davis, Jr.

Understanding the Fundamentals of the Employment Relationship:

We would be delighted to discuss your needs and how we could support you, so please get in touch. Our contact details appear on the final page.

Anna Haapanen. Profile

PROGRAMME. 10:00 10:45 Multi party, multi contract arbitration and consolidation

François G. Laugier's Representative Experience

Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency

T F White Collar, Compliance and Investigations > Anti-Corruption Compliance and Investigations >

Does your company know about IP rights and use them effectively to achieve business growth and protection?

Giovanna Tiberii Weller

Dorsey A Global Business Law Firm

*Ashish J. Thakkar Global Entrepreneurship Index

Sapna W. Palla. New York:

The Board is comprised of five members, three of whom are independent directors i.e. Mr Tan Cheng Han, Ms Ooi Chee Kar and Mr Rolf Gerber.

The Future of WTO Dispute Settlement

CPD half-day catch-up

Robert A. Greising Partner

Private Equity to us does not solely consist of preparing tailor-made acquisition, financing and exit structures, as well as developing and negotiatin

Helping Businesses & Investors. Succeed Across Saudi Arabia

Purvi B. Maniar Member of the Firm

The dos Santos Group at Morgan Stanley

OVER WHERE? Wednesday, April 30, 2014

Katten Shanghai Office TEAM

WIPO LIST OF NEUTRALS BIOGRAPHICAL DATA

SUSTAINABILITY REPORTING

IT-/IP-Law Intellectual Property Commercial and Corporate Law Labour Law

Mark Opashinov. Toronto education and year of call. profile

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

peace of mind For from development to commercial supply

PHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.

Public hearing VADEMECUM OF THE SPEAKERS

Transcription:

Magalie Wasem Tréguer Säntisstrasse 93, 8820 Wädenswil, Switzerland +41 (0)79 290 47 46 / +41 (0)43 343 94 91 mwasem@pharmalawsolutions.com Executive Summary International legal counsel trained at a leading global law firm with broad transactional, corporate and commercial experience Extensive expertise in regulatory and research and development legal matters having led the global clinical opera- tions support at a leading biotech and advised on complex clinical, regulatory and pharmacovigilance legal matters Robust expertise in the design and implementation of a global Compliance program in the pharmaceutical sector Sixteen years of experience as team leader or ad hoc project leader in Legal and Compliance departments Has set up her own consulting company in 2015 offering tailored legal and compliance advice to the life sciences industry 09/2015 Now Pharma Law Solutions, Zürich area Managing Partner Offering tailored legal and compliance advice to the pharmaceutical, biotechnology and medical device industry Biogen Idec International GmbH, Zug Senior Director, Compliance. Heading the Compliance Department for Europe and Canada Member of the European Leadership Team Responsible for the development, coordination and implementation of the Biogen Idec Corpo- rate Compliance Program in Region Europe. Managing a team of six Compliance officers and reporting to the Chief Compliance Officer Biogen Idec International GmbH, Zug Director, Legal Global lead for clinical operations and international regulatory and pharmacovigilance matters 10/2013 08/2015 08/2008 10/2013 Advising on global research and development activities and clinical operations in seventy countries as well as ex- US medical affairs, regulatory and drug safety matters. Manager of two paralegals supporting Research & Development (R&D) activities Biogen Idec International GmbH, Zug Senior Manager, Legal promoted to Associate Director, Legal. Commercial lawyer supporting the business within a broad territory 11/2004 08/2008 01/2001 11/2004 Responsible for on- going legal support to the Iberian, Benelux, French, Canadian affiliates and for the distribution markets in a vast number of countries. Lead advisor on anti- trust and com- petition matters ex- US Freshfields Bruckhaus Deringer, Paris Corporate lawyer in the Mergers & Acquisitions Department

Page 2 Job description and professional achievements 10/2013 08/2015 Biogen Idec International GmbH Senior Director, Compliance. Heading the Compliance Department for Europe and Canada Member of the European Leadership Team Key Responsibilities Managing the team of six senior Compliance officers responsible for the various clusters of countries in Europe and Canada and ensuring key partnership and alignment with the stand- ards and governance national roles existing across Europe Compliance head, member of the Biogen Idec European leadership team and representing the company at EFPIA Compliance key meetings Customizing and implementing the global Compliance program in Europe and Canada Establishing robust monitoring standards to ensure proactive risk awareness and high levels of legal compliance Ensuring creation and on- going updates of the relevant policies and standard operating proce- dures at regional and national level and relevant training to enhance governance standards Offering strategic advice with respect to the roll out of the program Managing department budget Key Achievements Fostering the credibility of the Compliance function and establishing a strong dialogue between the global function and the regional operations Ensuring the cohesion of the team and close partnership with Legal and Standards and Gov- ernance departments Leading a proactive Compliance and Governance committee overseeing the challenges across Europe and making aligned regional decisions Ensuring roll out of key compliance global and regional projects such as transparency EFPIA project, nurse services project, advisory boards project etc. 08/2008 10/2013 Biogen Idec International GmbH, Zug Director, Legal Global lead for clinical operations and international regulatory and pharmacovigilance matters Key responsibilities Managing the team of paralegals responsible for the daily advice to the research and develop- ment operational teams Building a robust repository of reference templates and legal opinions to ensure more efficient knowledge management Advising on complex research and development challenges involving legal, ethical, good clinical practice and data privacy issues Managing all legal aspects of the relationship with CROs, ethics committees and clinical sites Advising on pharmacovigilance, regulatory development and big data matters Leading role at the CT Legal (Clinical Trial Legal) inter- company forum hosted by Sidley Austin Key Achievements Awarded the Biogen Idec Leadership Price in 2009 Created best in class knowledge management platform with customized agreements and client friendly guidance to ensure autonomous speedy negotiations with the sites Designed comprehensive CRO negotiation guidelines to ensure the right levels of company controls while ensuring efficient negotiations Led the creation of the secondary research policy Led discussions with EMA on clinical data transparency

Page 3 11/2004 08/2008 Biogen Idec International GmbH, Zug Associate Director, Legal. Commercial lawyer supporting the business within a broad territory Key responsibilities Ensuring dedicated legal support to a number of affiliates (Spain, Portugal, France, Benelux, Canada) Lead lawyer for the distribution business in Europe, Middle East and Latin America Creating the new affiliates in Latin America (Brazil, Mexico, Argentina) and ensuring a smooth transition under the distribution agreements Anti- trust responsibility in Europe: managing strategic parallel trade legal challenges, author of the stock management scheme Lead legal support to the production and quality activities Key achievements Built a robust stock management scheme which allowed for a more accurate allocation of the drug at market level and was responsible for considerable company savings Ensured the transition of the business in Latin America from a distribution to a wholly- owned affiliate model Created adequate legal template repositories to further empower affiliates to contract Ensured all the legal support required for a successful transition of the quality activities from the Netherlands to Denmark 01/2001 11/2004 Freshfields Bruckhaus Deringer, Paris Supporting acquisitions of groups of companies in various jurisdictions Specific expertise in the representations and warranties from the vendor and subsequent arbi- tration cases Solid expertise in post- acquisition litigation and arbitration 1997 2001 Various trainings at leading law firms Summer internships at Stikeman, Elliott in Montreal, Canada Education and on- going professional development 2014 Graduated from INSEAD executive course on Compliance (Healthcare Compliance Implementation Leadership Programme) 2010 Completed a two year director development leadership program (DDP) at Biogen Idec 2008 Graduated from the ECPM degree at Basel University, Switzerland (2 year education mainly di- rected at clinical and regulatory professionals to better understand development steps from molecule to market) 2001 Qualification as a lawyer (Avocat à la Cour) at the Paris Bar Distinction: Paris Bar Chairman Award Laureate ( Lauréate du Bâtonnier ) 1999 2000 Graduation from Faculty of Law (University of Lyon III, France), Master of Law in Business and Tax Law ( DESS droit des Affaires et fiscalité /DJCE) Distinction: Year 2000 Valedictorian ( Major ) Essay presented on cross- border mergers ( Plaidoyer pour la fusion transnationale )

Page 4 1999 2000 Advanced Certificate in Company Law with the Faculty of Law - (University of Montpellier I) Distinction: Year 2000 Valedictorian ( Major ) and Laureate of the Charles Raynaud Award allocated by the French Association of In- House Lawyers (Association Française des Juristes d Entreprise- AFJE) Diploma in Common Law (English Law) from the Comparative Law Institute Edouard Lambert (University of Lyon III) With honours (Summa Cum Laude) ( Mention Très Bien, Major ) Essay presented on Canadian Bankruptcy Procedures in a comparative law approach ( La fail- lite en droit canadien ) 1995 1999 Bachelor of Law in Business Law (Maîtrise de Droit des Affaires) With honours (Summa Cum Laude) ( Mention Très Bien, Major ) 1995 High School Graduation (Baccalauréat) in Economics, with honors (Summa Cum Laude) ( Men- tion Très Bien ) IT skills MS Office (Word, Excel, Powerpoint) Languages English French German Spanish Russian Fluent Mother tongue Good level (Goethe Institut Zertifikat B2 Sehr Gut) Conversational basic knowledge Memberships Has been the Legal department representative of the Diversity and Inclusion Committee and an active organiser of the Women Innovation Network events at Biogen Idec Member of CT Legal (Clinical Trial Legal) Supporting Giving Women activities Publications, public speaking at conferences, teaching & recognitions 2016 Speaker at CT Legal Conference Seismic Shifts in EU Data Privacy, understanding impact of the Schrems decision in the conduct of international clinical trials 2015 Speaker at CT Legal Conference Mastering compliance risks: key to a successful R&D strategy 2014 Speaker at the International Pharma Compliance Congress with respect to the compliance chal- lenges in the R&D sponsor related activities 2010 2013 Regular speaker within the specialized Clinical Trial Legal forum CT Legal on key R&D issues such as secondary research, contracting with CRO, compliance challenges in the R&D area etc 2009 Winner of the Biogen Idec Leadership Award 2008 Speaker at the C5 Conference on the subject of transparency in the conduct of clinical trials

Page 5 2007 Speaker at the C5 Conference Pharmaceutical Patent Lifecycles on the subject of parallel trade in the pharmaceutical sector Rising to the challenge of Parallel Trade 2006 Speaker at the VIB Conference on the subject of Parallel Trade 2004 Publication in the business daily newspaper Les Echos : the impact of French foreign investment regulations on the merger project between Novartis and Aventis ( Comment l offre de Novartis a été freinée ), Les Echos, 27th April 2004 Organization of various seminars for the National Association of the DJCE (ANDJCE), for the French Association of In- House Lawyers (Association Française des Juristes d Entreprises- AFJE) and teaching business law at the Faculty of law of Montpellier and at the Paris Bar School Personal facts Address Säntisstrasse 93, 8820 Wädenswil Birth date 07 March 1977 Nationalities Swiss, Canadian & French Hobbies Traveling, cooking, hiking in the mountains, swimming, charity activities with- in the association Giving Women or the School Parents Committee Kids for Kids